Craig Harper-Denson - Jul 5, 2022 Form 4/A - Amendment Insider Report for Charge Enterprises, Inc. (CRGE)

Role: COO, CCO, Secretary, Director
Signature: /s/ JAMIE YUNG, Attorney-in-Fact
Stock symbol: CRGE
Transactions as of: Jul 5, 2022
Transactions value $: -$48,750
Form type: 4/A - Amendment
Date filed: 7/21/2022, 04:05 PM
Date Of Original Report: Jul 6, 2022
Previous filing: Jun 1, 2022
Next filing: Aug 31, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRGE	Common Stock, par value $0.0001	Options Exercise	$6.88K	+12.5K		$0.55	12.5K	Jul 5, 2022	By Spouse
transaction	CRGE	Common Stock, par value $0.0001	Gift	$0	-12.5K	-50%	$0.00	12.5K	Jul 5, 2022	By Spouse	F1
transaction	CRGE	Common Stock, par value $0.0001	Gift	$0	+12.5K		$0.00	12.5K	Jul 5, 2022	Direct	F1
transaction	CRGE	Common Stock, par value $0.0001	Sale	-$55.6K	-12.5K	-100%	$4.45	0	Jul 5, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRGE	Options, right to buy	Options Exercise	$0	-12.5K	-0.13%	$0.00	9.74M	Jul 5, 2022	Common Stock	12.5K	$0.55	By Spouse	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range. This Form 4 is being amended to reflect that the shares issued upon exercise of the option were gifted to the Reporting Person by Reporting Person's spouse and Reporting Person, as direct owner, disposed of the shares. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2022.
F2	On November 1, 2020, the Reporting Person's spouse was issued a ten-year option to purchase 10,500,000 shares of common stock. The vesting schedule for the remaining shares issuable upon exercise is: (i) 4,487,500 shares, which vested November 1, 2021; (ii) 2,625,000 shares will vest on November 1, 2022; and (iii) 2,625,000 shares will vest on November 1, 2023.

Content

The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range. This Form 4 is being amended to reflect that the shares issued upon exercise of the option were gifted to the Reporting Person by Reporting Person's spouse and Reporting Person, as direct owner, disposed of the shares. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2022.

On November 1, 2020, the Reporting Person's spouse was issued a ten-year option to purchase 10,500,000 shares of common stock. The vesting schedule for the remaining shares issuable upon exercise is: (i) 4,487,500 shares, which vested November 1, 2021; (ii) 2,625,000 shares will vest on November 1, 2022; and (iii) 2,625,000 shares will vest on November 1, 2023.